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INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia, hypertriglyceridaemia and hypercholesterolaemia, resulting from defects in insulin secretion or action or both 1 . Several attempts have been proposed to improve oral bioavailability, among them microencapsulation represents a promising concept 2 . Microencapsulation has been employed to sustain drug release, providing a long lasting and more reliable release with gastrointestinal (GI) irritation reduced or eliminated 3 .
Bioadhesive delivery of drugs has gained prominence in recent times as a means of drug administration. The intimate contact of the mucoadhesive polymer with the mucous surface can result in an increased drug retention time, increasing bioavailability and increasing contact time between drug and mucosa 4, 5, 6 . When the mucoadhesive dosage form is administered in either tablet or capsule form, they may or may not adhere to the mucous surface due to the weight of the dosage form and the vigorous movement of the GI tract, resulting in a large variation. However, mucoadhesive microspheres have some advantages. These include a light weight and a smaller dose variation due to the large number of microspheres administered 7 .
Rosiglitazone maleate (RSZ) is an antidiabetic drug for type II diabetes that improves insulin sensitivity in muscle and adipose tissues through activation of peroxidase proliferator-activated γ receptor (PPAR γ) that are involved in the transcription of insulin responsive genes responsible for glucose production, transport, and utilization 8 . The aim of the present work is to characterize the rosiglitazone microspheres with biological half-life of 3-4 h and to evaluate the usefulness and feasibility of these microspheres for orally administered drug delivery system.
MATERIALS AND METHODS

Materials
Rosiglitazone (RSZ) was obtained from Zydus Cadila, Ahmedabad, India. Sodium alginate (CDH, New Delhi), Calcium chloride (Qualigens, Mumbai), Hydroxypropylmethylcellulose (HPMC), K4M, Sodium carboxymethylcellulose (SCMC) and carbopol-934P (CP) were procured from Central Drug House, Mumbai. All other reagents used were of analytical grade and purchased from their respective commercial sources.
Methods
Preparation of Microspheres
Rosiglitazone microspheres were prepared by ionotropic gelation method 9 employing sodium alginate in combination with various polymers using sodium CMC, HPMC and carbopol 934P in different ratios (1:1, 1:9 and 9:1). Sodium alginate (1.0 g) was dissolved in purified water (50 ml) to form a homogeneous polymer solution with 1.0 g of each polymer. The drug RSZ (2.0 g) was added to the polymer solution and the resulting dispersion was added manually drop wise into 10% w/v of calcium chloride solution (about 40 ml) through a syringe with a needle size no.
18. The added droplets were retained in the calcium chloride solution for 30 min to complete the curing reaction.
The microspheres were collected by decantation, and the product thus separated was washed repeatedly with water and dried at 45° C for 12 hrs.
FT-IR Study
The Fourier transform infrared (FT-IR) spectra of pure drug (RSZ) and drug-polymer loaded microspheres were obtained using a Perkin-Elmer spectroscope. About 2-3 mg of samples were mixed with dried KBr of equal weight and compressed to form KBr disks. The samples were scanned from 400 to 4000 cm -1 .
Morphology and Particle size
Shape and surface morphology of microspheres were studied using Scanning Electron Microscope (SEM LEO 430, Leo Electron Microscopy Ltd., England). For determination of surface characteristics all the microspheres were coated uniformly with gold palladium by using sputter coater for 5 to 7 minutes, after fixing the sample in individual steps. All samples of microspheres were then randomly examined for surface morphology at different magnification ranges.
Particle size of the microcapsules was evaluated using optical microscopy method 10 . Approximately 100 microspheres were counted for particle size determination using a calibrated optical microscope (Magnus MLX-DX). The experiments were done in triplicate (n=3) 11 .
Micromeritic Properties of Microspheres
Accurately weighed microspheres were gently poured using a glass funnel into a graduated cylinder exactly to 10 ml mark. Initial volume was noted. Bulk density and taapped
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Angle of repose of prepared microspheres (n=3) was determined by fixed funnel standing method. The granules were allowed to flow through funnel orifice on a plane paper kept on the horizontal surface to form a pile of granules.
Angle of repose (θ), Hausner's ratio (H) and Carr's index (% C) were calculated to study the flow properties of microspheres by using following formulas 12 .
where, h is height and r is radius of the pile, respectively.
where, Dt is tapped and Db is bulk density, respectively.
Percentage Entrapment efficiency
50 mg of microspheres were dispersed in 10 ml of 0.1 N HCl for 30 min with occasional shaking. The suspension was then centrifuged at 2000 rpm for 5 min and the supernatant was kept aside. The drug concentration was determined spectrophotometrically by UV at 228 nm (Shimadzu Pharmspec UV-1700, Japan). The entrapment efficiency (n=3) was calculated by using following formula 13 .
where, Dcal is the calculated drug content and Dth is the theoretical drug content, respectively.
In-vitro wash-off test
Freshly excised pieces of intestinal mucosa (5 x 2 cm) from sheep were mounted onto glass slides (3 x 1 inch) with adhesive material 14 . About 50 microspheres were spread onto each wet rinsed tissue specimen, and immediately thereaf- 
In-vitro drug release of microspheres
A USP XXIII basket type dissolution apparatus was used to study in-vitro drug release from microspheres. A weighed amount of microspheres (50 mg) was used for the study. 900 ml of dissolution medium (0.1N HCl, pH 1.2) maintained at a temperature of 37±0.5°C and rotation speed of 100 rpm was used for the study 15 . The in-vitro release studies were performed for 12 h. At predetermined time intervals, 5 ml sample was withdrawn, passed through a 0.45 µm membrane filter (Millipore). After appropriate dilutions, the concentration of drug in samples were analysed spectrophotometrically at 228 nm using Shimadzu, Pharmspec UV-1700 series, Japan. The initial volume of dissolution medium was maintained by adding 5 ml of fresh dissolution medium after each withdrawal. Perfect sink conditions prevailed during the in-vitro drug release studies.
Statistical analysis
Experimental results were performed in triplicate (n=3) and expressed as mean ± S.D. One-way analysis of variance (ANOVA) was applied to check significant difference in drug release from different formulations. Differences were considered to be significant at P<0.05.
RESULTS AND DISCUSSION
FTIR Study
Potential 
Physical characterization of microspheres
The microspheres were found to be discrete, spherical and free-flowing. The effects of alginate concentrations and Garud, A. y Garud, N.
polymer ratios on the average particle size and % drug entrapment of microspheres are shown in Table 1 . The mean particle size increased with increase in polymer concentration which might be due to the fact that as polymer concentration increases it produces a significant increase in the viscosity, leading to an increase of the emulsion droplet size and finally a higher microsphere size.
The % entrapment efficiency for the different formulations significantly increased with increasing polymer content (p<0.05). The alginate-CP microspheres (9:1) produced the highest % entrapment efficiency of 85.6±3.2. An increase in polymer concentration resulted in formation of larger microspheres entrapping greater amount of drug 16 .
The size of the microspheres increased with increase in the alginate concentration which may be due to the increase in viscosity, resulting in increase in droplet size during addition of the polymer dispersion to the harvesting medium.
The SEM of prepared microspheres (F1) is shown in Figure   1 . Formation of cracks on the surface of the microspheres were observed which may be due to the penetration of the dissolution medium into the microspheres and the subsequent dissolution of the drug and hence its diffusion through the polymer matrix. Formulation of mucoadhesive microspheres of rosiglitazone maleate and its in vitro evaluation using ionotropic gelation technique
Micromeritic properties of microspheres
The rheological parameters like angle of repose, tapped density, bulk density and packing properties (Table 1) confirms better flow and packing properties of the prepared microspheres. All the formulation showed angle of repose value within the range of 30° to 45° (n=3), which is an appreciable limit for microspheres to show flow property while formulating in the dosage form.
In-vitro wash-off studies
The mucoadhesion test was performed on both simulated gastric pH (0.1N HCl, pH 1.2) and simulated intestinal pH (phosphate buffer solution, PBS, pH 6.8) for 12h. The results are given in Table 2 . Ch'ng et al. (1985) observed that the pH of the medium was critical for the degree of hydration, swelling and mucoadhesion of the polymers 17 . The wash-off was found to be faster at intestinal pH than at gastric pH. The rapid wash-off observed at simulated intestinal pH 6.8 may be due to ionization of carboxyl acid group and other functional groups present in the polymers at this pH, which increases their solubility and reduces adhesive strength.
The adhesion time of microspheres at pH 1.2 was ranked, HPMC > carbopol 934P, whereas the adhesion time for the microspheres at pH 6.8 was ranked, carbopol 934P > HPMC. Poor mucoadhesion of HPMC microspheres at alkaline pH may be due to its non-ionic nature possessing low hydrogen bonding capability with mucus glycoproteins 18 . Although carbopol 934P microspheres had negative charge repulsion with mucus, numerous hydrophilic functional groups such as carboxyl groups in carbopol molecules could form hydrogen bonds with mucus molecules, thus producing some adhesive force of this polymer. The microspheres produced using alginate: SCMC coat did not adhere to the mucosa for more than 6 h showing poor mucoadhesion in either of the pH mediums used for the study. 
In-vitro drug release of microspheres
Solubility of RSZ depends on pH. Maximum absorption may be expected with increasing solubility in acid environment. It is known that microspheres constitute multipleunit dosage forms which have many advantages as compared to tablets. They spread more evenly in the stomach which leads to a decreased risk of high local concentration and of adverse effects. Moreover, these forms are characterized by a high reproducibility of release due to a relatively large surface and a short diffusion way of the drug 19 .
The in-vitro release studies were carried out in 0.1 N HCl (pH 1.2) which indicated that there was a slow and controlled release of drug for all the formulations. The drug release of the microspheres at 1:9 and 9:1 ratio of alginate: Garud, A. y Garud, N. polymers are shown in Figure 2 and 3, respectively. Drug release from the RSZ microspheres was slow, extended and dependent on the type of polymer used. The increasing order of release rate observed with microspheres was Sodium alginate: Sodium CMC < Sodium alginate: Carbopol < Sodium alginate: HPMC. The differences in the drug release characteristics of various microspheres might be due to the differences in the porosity of the coat formed and its solubility in the dissolution fluid. Drug release from alginatesodium-CMC was slow and extended over a period of 12 hr and these microcapsules were found suitable for oral controlled release formulations. 
